141 related articles for article (PubMed ID: 7684479)
21. [Anti-HBc IgM in HBsAg-negative chronic hepatitis].
Rodríguez M; Pérez R; Sala P; Rodrigo L
Med Clin (Barc); 1985 Jun; 85(5):209-10. PubMed ID: 4021640
[No Abstract] [Full Text] [Related]
22. [Severe exacerbation of chronic hepatitis B following interferon therapy].
Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
[TBL] [Abstract][Full Text] [Related]
23. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
Cianciara J; Laskus T
Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous reactivation of chronic hepatitis B infection leading to fulminant hepatic failure. Report of two cases and review of the literature.
Meyer RA; Duffy MC
J Clin Gastroenterol; 1993 Oct; 17(3):231-4. PubMed ID: 8228085
[TBL] [Abstract][Full Text] [Related]
25. Chronic viral hepatitis--benefits of current therapies.
Hoofnagle JH; Lau D
N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
[No Abstract] [Full Text] [Related]
26. [Delta virus: now also detected in Austria. A defective virus as a pathogenic agent].
Frisch-Niggemeyer W; Kunz C
Wien Klin Wochenschr; 1985 May; 97(10):460-3. PubMed ID: 4013341
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
28. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
Ruiz-Moreno M; Rúa MJ; Moraleda G; Guardia L; Moreno A; Carreño V
Pediatrics; 1992 Aug; 90(2 Pt 1):254-8. PubMed ID: 1641292
[TBL] [Abstract][Full Text] [Related]
29. [Chronic infection due to hepatitis B virus in patients less than 16 years of age: therapeutic approach by means of interferon alfa-2b].
Vetencourt R; Oropeza F; de Armas J; Cordero I; de Silva M; Machado I; Vetencourt M; Mendoza J
G E N; 1990; 44(4):353-60. PubMed ID: 2152277
[TBL] [Abstract][Full Text] [Related]
30. The A to F of viral hepatitis.
Lancet; 1990 Nov; 336(8724):1158-60. PubMed ID: 1978030
[No Abstract] [Full Text] [Related]
31. [Treatment of chronic hepatitis B and C with alpha interferon].
Hess G
Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
[No Abstract] [Full Text] [Related]
32. The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.
Yoo YK; Gavaler JB; Chen K; Whiteside TL; van Thiel DH
Clin Exp Immunol; 1990 Nov; 82(2):338-43. PubMed ID: 2242614
[TBL] [Abstract][Full Text] [Related]
33. Interferon alfa-2b therapy in children with chronic hepatitis B.
Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of delta antigen/antibody in various HBsAg positive patients in Saudi Arabia.
Shobokshi OA; Serebour FE
Prog Clin Biol Res; 1987; 234():471-5. PubMed ID: 2819896
[No Abstract] [Full Text] [Related]
35. Loss of HBsAg with interferon-alpha therapy in chronic hepatitis D virus infection.
Lau JY; King R; Tibbs CJ; Catterall AP; Smith HM; Portmann BC; Alexander GJ; Williams R
J Med Virol; 1993 Apr; 39(4):292-6. PubMed ID: 8492101
[TBL] [Abstract][Full Text] [Related]
36. Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trial.
Rakela J; Wood JR; Czaja AJ; O'Brien PC; Taswell HF; Bowyer BA; Lange SM; Anderson ML; Parent K
Mayo Clin Proc; 1990 Oct; 65(10):1330-5. PubMed ID: 2214880
[TBL] [Abstract][Full Text] [Related]
37. The impact of previous HBV infection on the course of chronic hepatitis C.
De Maria N; Colantoni A; Friedlander L; Leandro G; Idilman R; Harig J; Van Thiel DH
Am J Gastroenterol; 2000 Dec; 95(12):3529-36. PubMed ID: 11151889
[TBL] [Abstract][Full Text] [Related]
38. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
[No Abstract] [Full Text] [Related]
39. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
Oketani M; Tanaka K; Sho Y; Maeda E; Miyazaki H; Arima T
Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
[TBL] [Abstract][Full Text] [Related]
40. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
